retatrutide clinical trial weight loss data Before and After: Doctor Reveals Real Results Effects of once-weekly subcutaneous retatrutide
Description
The metabolic benefits were too important
The relatively lower nausea rate compared to Semaglutide (44%) represents a notable advantage
Participants were recruited through ResearchMatch and snowball sampling
Davies M, Pieber TR, Hartoft-Nielsen ML, Hansen OK, Jabbour S, Rosenstock J
However, genetics alone do not guarantee outcomes
The role of the gut microbiota in NAFLD
